[Federal Register Volume 69, Number 152 (Monday, August 9, 2004)]
[Notices]
[Pages 48247-48249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18072]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 69 FR 17166-17167, dated April 1, 2004) is 
amended to reorganize the Division of Parasitic Diseases, National 
Center for Infectious Diseases.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the functional statement for the Division of 
Parasitic Diseases (CRS) and insert the following:
    Division of Parasitic Diseases (CRS). (1) Conducts surveillance, 
investigations, and studies of parasitic diseases to define disease 
etiology, mode of transmission, and populations at risk and to develop 
effective methods for diagnosis, prevention, control, and elimination; 
(2) conducts or participates in clinical, field, and laboratory 
research to develop, evaluate, and improve laboratory methodologies and 
materials and therapeutic practices used for rapid and accurate 
diagnosis and treatment of parasitic diseases; (3) provides epidemic 
aid and epidemiologic consultation, upon request, to State and local 
health departments, other Federal agencies, and national and 
international health organizations; (4) provides reference/diagnostic 
services for parasitic diseases to State and local health departments, 
other Federal agencies, and national and international health 
organizations; (5) conducts a program of research and development in 
the biology, ecology, host-parasitic relationships, and control of 
parasitic diseases; (6) conducts laboratory studies of selected 
parasitic infections, emphasizing animal models and in vitro systems 
for parasitic relationships, chemotherapy, and immunology, to develop 
effective methods for diagnosis, prevention, and

[[Page 48248]]

control; (7) provides scientific and technical assistance to other 
components within NCID or CDC when the work requires unique expertise 
or specialized equipment not available in other NCID or CDC components; 
(8) provides intramural and extramural technical expertise and 
assistance in professional training; (9) serves as World Health 
Organization (WHO) Collaborating Centers for Cysticercosis, Research 
Training and Control of Dracunculiasis, Control and Elimination of 
Lymphatic Filariasis, Evaluating and Testing New Insecticides, 
Insecticide Resistance, Insect Vectors; Malaria Control in Africa, 
Human African Trypanosomiasis, Production and Distribution of Malaria 
Sporozoite ELISAs, Collaborating Centers for Eradication of Guinea 
Worm; (10) maintains field-based research stations in Guatemala in 
collaboration with Universidad del Valle de Guatemala, and in Kenya in 
collaboration with KEMRI; (11) carries out this mission in a workplace 
that promotes professional development and recognizes the importance of 
the individual and the team; (12) provides communication support to 
enhance overall methods of dissemination of credible information to the 
public, local and state health officials, international partners and 
private funders in order to inform health decisions to prevent and 
control parasitic diseases in the United States and abroad. The 
services are provided through the partnerships with health care 
professionals, state, local and federal agencies with the United 
States, foreign governments, national and international organizations, 
and the public.
    Delete in its entirety the functional statement for the Data 
Management Activity (CRS-2) and insert the following:
    Data Management Activity (CRS12). (1) Provides statistical and 
information systems consultation for study design and protocol 
development; (2) designs and implements database management systems 
(including geographic information systems) in support of the Division 
of Parasitic Diseases (DPD) projects; (3) provides data analysis and 
statistical consultations in support of DPD projects; develops new 
methodologies as needed; (4) assists in production of and provides 
graphics support for presentations and manuscripts related to DPD 
objectives; (5) evaluates new software for statistical analysis, 
database management, graphics production, map creation, geographical 
information systems, and other functions related to DPD objectives and 
provides support for division activities in these areas.
    Delete the title and functional statement for the Parasitic 
Diseases Epidemiology Branch (CRS2) and insert the following:
    Parasitic Diseases Branch (CRS2). (1) Investigates outbreaks and 
unusual occurrences of parasitic diseases when requested by State 
departments, ministries of health, the World Health Organization (WHO), 
and other agencies and organizations; (2) conducts surveillance of 
waterborne disease outbreaks and other parasitic diseases in the United 
States; (3) provides reference and laboratory diagnostic services to 
physicians and laboratories; (4) transfers technologies and expertise 
in laboratory diagnosis of parasitic infections to public health 
laboratories; (5) provides consultation on the treatment and management 
of parasitic diseases to clinicians, laboratorians, departments of 
health, and other agencies; (6) provides otherwise unavailable anti-
parasitic drugs to healthcare providers and ensures compliance with the 
Food and Drug Administration's regulations; (7) provides leadership and 
technical expertise in support of the agency's bioterrorism 
preparedness response initiatives as they relate to waterborne venues; 
(8) supports the agency's overall emergency response mandate; (9) 
conducts research on methods to detect parasites and agents of 
bioterrorism in water, and developing emergency public health response 
plans; (10) conducts field and laboratory investigations and research 
on the etiology, biology, epidemiology, ecology, pathogenesis, 
immunology, genetics, host-parasitic relationships, chemotherapy and 
other aspects of parasitic diseases to develop new tools for 
identifying and controlling parasitic diseases; (11) develops and tests 
new laboratory methods and tools for improved diagnosis, control, and 
prevention of parasitic diseases; (12) evaluates current strategies and 
develops new strategies for the control and elimination of parasitic 
diseases; (13) carries out and evaluates operational research to 
support programmatic activities; (14) provides technical assistance to 
ministries of health, the World Health Organization, and other agencies 
and organizations for these programs; (15) plans, implements and 
evaluates such programs; (16) provides training to EIS officers, 
Emerging Infectious Disease Fellow, AMS/NCID Postdoctoral Fellows, 
Preventive Medicine Residents, Public Health Prevention Specialists, 
and other fellows and students; (17) prepares educational materials on 
the prevention and treatment of parasitic diseases; (18) conducts 
laboratory training courses for public health laboratories; (19) 
prepares and disseminates health communication materials.
    Delete in its entirety the functional statement for the Entomology 
Branch (CRS3) and insert the following:
    Entomology Branch (CRS3). (1) Conducts laboratory and field 
research to develop, evaluate, and implement effective surveillance and 
vector arthropod control strategies; (2) develops and utilizes 
analytical methods for the use of pesticides for the control of vector-
borne diseases, identification and quantification of anti-parasitic 
drugs, pharmaceutical products, and their metabolites in body fluids 
and tissues of humans and other animals; (3) serves as a WHO 
Collaborating Center or as an international standardized reference 
reagent and vector repository for methods development, training, 
surveillance, and research for insecticide resistance, vector 
identification, antimalarial drug evaluation, host-vector 
relationships, vector control; (4) provides entomological consultation 
and training to local, State, foreign and international health 
organizations on surveillance and control of vectors and vector-borne 
diseases; (5) conducts studies or collaborates on other disease 
surveillance and control initiatives as needed.
    Delete in their entirety the title and functional statement for the 
Biology and Diagnostics Branch (CRS4).
    Delete in their entirety the title and functional statement for the 
Immunology Branch (CRS5).
    Delete in its entirety the title and functional statement for the 
Malaria Epidemiology Branch (CRS6) and insert the following:
    Malaria Branch (CRS6). (1) Conducts malaria surveillance, 
prevention, and control in U.S. residents and visitors, including 
monitoring the frequency and distribution of malaria cases that occur 
in U.S. residents and visitors; monitoring the efficacy and safety of 
antimalarial drugs for chemoprophylaxis and chemotherapy; offering 
clinical advice and epidemiologic assistance on the treatment, control, 
and prevention of malaria in the United States and in malaria endemic 
countries; and providing information to the U.S. public and to agencies 
or groups serving this population on appropriate measures to prevent 
and control malaria; (2) provides consultation, technical assistance, 
and training to malaria-endemic countries and to international and 
United States agencies and

[[Page 48249]]

organizations on issues of malaria prevention and control; (3) conducts 
epidemiologic, laboratory, and field-based research projects, in 
support of Malaria Branch mandates (1 and 2 above), 
including laboratory and field studies on parasitic diseases to define 
biology, ecology, transmission dynamics, parasite species differences, 
host-parasite relationships, diagnostics, host immune responses, 
populations at risk, and determinants of morbidity and mortality; (4) 
conducts laboratory studies of malaria parasites, emphasizing animal 
models and in vitro systems for parasitic relationships, chemotherapy, 
and vaccine evaluation studies; (5) conducts field studies of malaria 
prevention and control tools and strategies; (6) conducts assessments 
of malaria monitoring and evaluation methods and program use of these 
methods.

    Dated: July 27, 2004.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention 
(CDC).
[FR Doc. 04-18072 Filed 8-6-04; 8:45 am]
BILLING CODE 4160-18-M